Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
SPS Commerce
SPSC
$2.69B
| $14.8M | ﹤0.01% |
108,595
+57,101
| +111% | +$7.91M |
|
1302
Euronet Worldwide
EEFT
$2.65B
| $14.8M | ﹤0.01% |
145,621
+13,597
| +10% | +$1.41M |
|
1303
CALL
Johnson & Johnson
JNJ
$631B
| $14.8M | ﹤0.01% |
96,600
-1,034,900
| -91% | -$159M |
|
1304
CALL
Delta Air Lines
DAL
$58.7B
| $14.8M | ﹤0.01% |
300,000
+182,600
| +156% | +$8.38M |
|
1305
Telefônica Brasil
VIV
$19.1B
| $14.7M | ﹤0.01% |
1,290,641
-32,537
| -2% | -$320K |
|
|
EVRI
1306
DELISTED
Everi Holdings
EVRI
| $14.7M | ﹤0.01% |
1,028,999
+836,155
| +434% | +$11.7M |
|
1307
CALL
nVent Electric
NVT
$26.3B
| $14.7M | ﹤0.01% |
200,000
| – | – |
|
1308
AptarGroup
ATR
$8.5B
| $14.6M | ﹤0.01% |
93,476
-40,038
| -30% | -$6.05M |
|
1309
PUT
W.W. Grainger
GWW
$61.1B
| $14.6M | ﹤0.01% |
14,000
| – | – |
|
1310
ADMA Biologics
ADMA
$2.18B
| $14.5M | ﹤0.01% |
798,720
+352,837
| +79% | +$7.19M |
|
1311
CALL
Hims & Hers Health
HIMS
$7.35B
| $14.5M | ﹤0.01% |
291,600
+250,000
| +601% | +$11.3M |
|
1312
Peloton Interactive
PTON
$2.42B
| $14.5M | ﹤0.01% |
2,092,115
+746,281
| +55% | +$4.85M |
|
1313
Group 1 Automotive
GPI
$3.16B
| $14.5M | ﹤0.01% |
33,226
+14,678
| +79% | +$6.16M |
|
1314
Bath & Body Works
BBWI
$3.89B
| $14.5M | ﹤0.01% |
482,692
-312,778
| -39% | -$9.15M |
|
1315
Integer Holdings
ITGR
$4.25B
| $14.4M | ﹤0.01% |
117,504
+3,871
| +3% | +$462K |
|
|
SNV
1316
DELISTED
Synovus
SNV
| $14.4M | ﹤0.01% |
278,435
-33,838
| -11% | -$1.56M |
|
|
CWAN
1317
DELISTED
Clearwater Analytics
CWAN
| $14.4M | ﹤0.01% |
655,271
+283,593
| +76% | +$6.52M |
|
1318
CALL
Lockheed Martin
LMT
$139B
| $14.4M | ﹤0.01% |
31,000
-11,100
| -26% | -$5.2M |
|
1319
Magna International
MGA
$18.7B
| $14.3M | ﹤0.01% |
370,064
-300,574
| -45% | -$10.6M |
|
1320
RH
RH
$3.47B
| $14.3M | ﹤0.01% |
75,545
-70,533
| -48% | -$13.1M |
|
1321
Unum
UNM
$14.5B
| $14.3M | ﹤0.01% |
176,571
-84,088
| -32% | -$6.64M |
|
1322
Vaxcyte
PCVX
$8.67B
| $14.3M | ﹤0.01% |
438,409
+212,287
| +94% | +$6.96M |
|
1323
CALL
Ultragenyx Pharmaceutical
RARE
$2.64B
| $14.2M | ﹤0.01% |
391,600
+351,700
| +881% | +$12.7M |
|
|
PENG
1324
Penguin Solutions Inc
PENG
$2.83B
| $14.2M | ﹤0.01% |
718,545
+61,390
| +9% | +$1.11M |
|
|
CIVI
1325
DELISTED
Civitas Resources
CIVI
| $14.2M | ﹤0.01% |
516,990
+105,888
| +26% | +$3.07M |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.